SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-020636
Filing Date
2024-05-20
Accepted
2024-05-20 14:57:57
Documents
43
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 630797
2 ex31-1.htm EX-31.1 18018
3 ex31-2.htm EX-31.2 18096
4 ex32-1.htm EX-32.1 6857
5 ex32-2.htm EX-32.2 6714
  Complete submission text file 0001493152-24-020636.txt   2799718

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE btax-20240331.xsd EX-101.SCH 21684
7 XBRL CALCULATION FILE btax-20240331_cal.xml EX-101.CAL 27347
8 XBRL DEFINITION FILE btax-20240331_def.xml EX-101.DEF 48094
9 XBRL LABEL FILE btax-20240331_lab.xml EX-101.LAB 169663
10 XBRL PRESENTATION FILE btax-20240331_pre.xml EX-101.PRE 123705
46 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 375489
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Biostax Corp. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 24963920
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)